Douvlataniotis K, Titov A, Zeun J, Bilici M, Palashati H, Loh W, Rustad EH, Yang W, Tran TT, Lund-Johansen F, Bollineni RC, Kepple JD, Huth LP, Munthe LA, Boxaspen T, Schjesvold F, Waage A, Wagner DL, Bull KR, Hester J, Issa F, Giannakopoulou E, Olweus J (2026)
TCR T cells targeting IgA- and IgG-expressing multiple myeloma
Blood (in press)
DOI 10.1182/blood.2025031897, PubMed 41770814

Dimopoulos MA, Boccadoro M, Einsele H, Rodriguez-Otero P, Hulin C, Perrot A, Leleu X, Caillot D, Facon T, Mina R, Gay F, Broijl A, Hajek R, Spencer A, Schjesvold F, Zweegman S, Nair S, Ammann E, He J, Nobrega M, Rowe M, Sitthi-Amorn A, Sonneveld P (2026)
Indirect treatment comparison of DVRd plus DR maintenance (PERSEUS study) versus DVTd or VTd with or without lenalidomide maintenance in transplant-eligible patients with previously untreated multiple myeloma
J Med Econ, 29 (1), 421-430
DOI 10.1080/13696998.2026.2624972, PubMed 41701105

Norseth HML, Askeland FB, Abrahamsen I, Schjesvold F (2026)
Resetting Sensitivity to T Cell Redirection by Tumor Reduction and Immune Modulation
Clin Lymphoma Myeloma Leuk (in press)
DOI 10.1016/j.clml.2026.01.005, PubMed 41656130